Welcome To Our Site!
Established in May, 2005, Weihai Disu Pharmaceutical Co., Ltd., is a subsidiary of Disha Pharmaceutical
Group, and a national high-tech enterprise.
Relying on the R&D strength of DiSha Pharmaceutical Group, Weihai DiSu Pharmaceutical Co.,Ltd has eight
professional institutes which provide product development, process optimization and other technical services. With
outstanding strength in scientific research and technological innovation ,it is a leader in pharmaceutical intermediates,
veterinary drug, marine biological products and so on.
The company's products strictly enforce the standards of Ch.P, Eh.P, USP and JP. In 2011,Disu Pharmaceutical
Co., Ltd. became Shandong's first and China's second API manufacturer to get 2010 GMP certificate.
The company has a number of workshops approved by veterinary drug GMP certification, has seven veterinary
drug approval numbers now ,and more than 10 varieties are being applied. The production is strictly in accordance
with the national GMP standard and has perfect quality testing and quality assurance system. Products can conform
to the CP, BP, USP, EP standard, etc. In terms of quality management concept and technology level, The company
is at the leading level in China.
The company is committed to research and development, production and sales of pharmaceutical intermediates,
veterinary drug substances, marine biological products and provides product customization, order processing
and technical services, etc.
Disu Pharmaceutical Co., Ltd. invests two new plants in Weihai, one is in Gushan Town, covering an area of
70,000 square meters, with construction standard complies strictly with the requirements of EU and American GMP
standard. The other is in Wendeng City, and now the first phase construction is under go and the second phase construction
is under overall design.
Weihai Disu can offer not only high quality API, but also accept OEM from Lab study to commercial manufacturing
efficiently.
Weihai Disu always maintains the business philosophy of integrity management ,and is willing to cooperate with
new and old customers to create brilliant!
Process Capability : ● Certificate No.UK GMP 45044 Insp GMP
45044/12737585-0001
● CEP Certificate of Glipizide (CEP 2012-117)
● Loxoprofen sodium has been approved by
Korea FDA
● More Than 300 Researchers in R& D department
● Offer High Quality APIs & Intermediates
● Offer Customized Service from Scientific Development
to Manufacturing
Our product loxoprofen sodium, candesartan cilexetil, (s)-amlodipine besylate, flavoxate hcl, flunarizine hcl
and glipizide can all reach the international standard and their sales are No.1 in China marketing share. Now
Glipizide API has got CEP certificate， Loxoprofen sodium API has been approved by Korea FDA，Solifenacin succinate for FDA registration is in process.
After-sale Service : Our product loxoprofen sodium, candesartan cilexetil, (s)-amlodipine besylate, flavoxate hcl, flunarizine hcl
and glipizide can all reach the international standard and their sales are No.1 in China marketing share. Now
Glipizide API has got CEP certificate， Loxoprofen sodium API has been approved by Korea FDA，Solifenacin
succinate for FDA registration is in process.
Certificate
China (Mainland)